Aptose Biosciences Inc (APTO)

Mar 07, 2025

Aptose Biosciences, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 05, 2025

Aptose Biosciences (NASDAQ:APTO) Earns Sell Rating from Analysts at StockNews.com - Defense World

Mar 05, 2025

Mar 03, 2025

Aptose Biosciences (NASDAQ:APTO) Upgraded at Alliance Global Partners - Defense World

Mar 03, 2025

Mar 02, 2025

Aptose Biosciences (TSE:APS) Upgraded at Alliance Global Partners - Defense World

Mar 02, 2025

Feb 28, 2025

Aptose Biosciences Inc. (NASDAQ:APTO) Short Interest Update - MarketBeat

Feb 28, 2025

Feb 28, 2025

Investor Network: Aptose Biosciences Inc. to Host Earnings Call - ACCESS Newswire

Feb 28, 2025

Feb 27, 2025

Aptose Biosciences Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Aptose Biosciences initiated with a Speculative Buy at Alliance Global Partners - TipRanks

Feb 27, 2025

Feb 27, 2025

Aptose's leukemia drug cleared to double clinical trial dose - MSN

Feb 27, 2025

Feb 26, 2025

Aptose Biosciences Inc (NASDAQ: APTO) Stock Sentiment: What’s Wall Street Saying? - Stocks Register

Feb 26, 2025

Feb 25, 2025

Aptose Biosciences (NASDAQ:APTO) Now Covered by StockNews.com - Defense World

Feb 25, 2025

Feb 22, 2025

Aptose Biosciences finalizes reverse stock split - Investing.com India

Feb 22, 2025

Feb 22, 2025

Aptose Biosciences Stock to Reverse Split on Wednesday, February 26th (NASDAQ:APTO) - Defense World

Feb 22, 2025

Feb 21, 2025

Aptose Biosciences finalizes reverse stock split By Investing.com - Investing.com Canada

Feb 21, 2025

Feb 20, 2025

Aptose Announces Positive Clinical Safety Review Committee - GlobeNewswire

Feb 20, 2025

Feb 20, 2025

Aptose advances AML treatment with higher dose in trial By Investing.com - Investing.com Nigeria

Feb 20, 2025

Feb 20, 2025

Why Is Penny Stock Aptose Biosciences Trading Higher On Thursday? - Benzinga

Feb 20, 2025

Feb 20, 2025

Aptose Biosciences Moves Forward With TUS Escalation In TUSCANY Trial After Positive Data - Nasdaq

Feb 20, 2025

Feb 20, 2025

Aptose's leukemia drug cleared to double clinical trial dose | 2025-02-20 | Investing News - Stockhouse Publishing

Feb 20, 2025

Feb 20, 2025

Aptose advances AML treatment with higher dose in trial - Investing.com India

Feb 20, 2025

Feb 20, 2025

Aptose Biosciences Brief: This Amid "Complete Responses and Favorable Safety in First Cohort" - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

Aptose Biosciences Brief: Announcing "Positive" Clinical Safety Review Committee Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

Breakthrough in AML Treatment? Aptose's Triple Drug Therapy Achieves Complete Responses in First Trial Cohort - StockTitan

Feb 20, 2025

Feb 19, 2025

Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga India

Feb 19, 2025

Feb 19, 2025

US Stocks Likely To Open Lower Following Fresh Records From Previous Session: Expert Says, 'Don't Be Scared Of New Highs' - Benzinga

Feb 19, 2025

Feb 18, 2025

Aptose Biosciences plans reverse stock split to meet Nasdaq rules By Investing.com - Investing.com Canada

Feb 18, 2025

Feb 18, 2025

Aptose Biosciences approves 1-for-30 reverse share split to restore Nasdaq compliance - MSN

Feb 18, 2025

Feb 18, 2025

Aptose Biosciences Announces Reverse Share Split - TipRanks

Feb 18, 2025

Feb 18, 2025

Aptose Biosciences plans reverse stock split to meet Nasdaq rules - Investing.com India

Feb 18, 2025

Feb 18, 2025

Aptose Biosciences Inc. Announces Reverse Share Split to Enhance Compliance with Nasdaq Listing Requirements - Nasdaq

Feb 18, 2025

Feb 18, 2025

Aptose Announces Reverse Share Split - GlobeNewswire

Feb 18, 2025

Feb 18, 2025

Aptose Takes Bold Action: 30-to-1 Share Consolidation to Secure Nasdaq Future - StockTitan

Feb 18, 2025

Feb 18, 2025

US Stocks Likely To Open Higher Amid Ukraine Peace Talk Hopes As Russian, American Officials Meet - Benzinga India

Feb 18, 2025

Feb 18, 2025

Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket - Benzinga India

Feb 18, 2025

Feb 17, 2025

Aptose Biosciences (NASDAQ:APTO) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 17, 2025

Feb 14, 2025

Aptose Biosciences announces resale of 12.03M shares by Keystone Capital Partners - MSN

Feb 14, 2025

Feb 14, 2025

Aptose Biosciences secures $25 million equity facility - MSN

Feb 14, 2025

Feb 14, 2025

Aptose Biosciences (NASDAQ:APTO) Earns “Buy” Rating from HC Wainwright - Defense World

Feb 14, 2025

Feb 14, 2025

Aptose Biosciences Inc. (NASDAQ: APTO) Issues Press Release on February 12, 2025 - Defense World

Feb 14, 2025

Feb 13, 2025

Aptose Biosciences Secures $25M Share Purchase Agreement - TipRanks

Feb 13, 2025

Feb 13, 2025

Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility - GlobeNewswire

Feb 13, 2025

Feb 13, 2025

Aptose Biosciences secures $25 million equity facility By Investing.com - Investing.com Canada

Feb 13, 2025

Feb 13, 2025

Aptose Biosciences Enters $25 Million Common Share Purchase Agreement to Support AML Therapy Development - Nasdaq

Feb 13, 2025